We are live on ! Find out more
NVCT icon

Nuvectis Pharma
NVCT

40 hedge funds and large institutions have $12.8M invested in Nuvectis Pharma in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

25% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 12

11% more funds holding

Funds holding: 36 → 40 (+4)

0% less capital invested

Capital invested by funds: $12.8M → $12.8M (-$3.31K)

0.07% less ownership

Funds ownership: 8.86% → 8.79% (-0.07%)

Holders
40
Holders Change
+4
Holders Change %
+11.11%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
15
Reduced
12
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$215K
2
BZWA
Blue Zone Wealth Advisors
California
+$122K
3
BWP
Baldwin Wealth Partners
Massachusetts
+$103K
4
GCP
GSA Capital Partners
United Kingdom
+$102K
5
State Street
State Street
Massachusetts
+$94.4K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$214K
2
Two Sigma Investments
Two Sigma Investments
New York
-$190K
3
BlackRock
BlackRock
New York
-$129K
4
Morgan Stanley
Morgan Stanley
New York
-$39.4K
5
Bank of America
Bank of America
North Carolina
-$31.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$28.8K +$29.8K +3,509 New
Wells Fargo
27
Wells Fargo
California
$18K +$2.53K +298 +16%
Citigroup
28
Citigroup
New York
$11.3K +$2.33K +274 +25%
TRCT
29
Tower Research Capital (TRC)
New York
$6.98K -$3.63K -427 -33%
Legal & General Group
30
Legal & General Group
United Kingdom
$6.9K – – –
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$6.13K -$4.06K -477 -39%
AIP
32
Ameritas Investment Partners
Nebraska
$4.64K – – –
TCOV
33
Trust Company of Vermont
Vermont
$4.1K +$4.25K +500 New
Fidelity Investments
34
Fidelity Investments
Massachusetts
$3.57K +$3.68K +433 +21,650%
HCM
35
Hollencrest Capital Management
California
$2.3K – – –
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$2K -$17.7K -2,077 -88%
AB
37
Amalgamated Bank
New York
$2K -$6.28K -739 -76%
NS
38
NBC Securities
Alabama
$1K +$850 +100 New
GI
39
GAMMA Investing
California
$205 +$213 +25 New
AWM
40
Avior Wealth Management
Nebraska
$8 +$9 +1 New
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
– -$214K -25,670 Closed
Two Sigma Investments
42
Two Sigma Investments
New York
– -$190K -22,771 Closed
1
2

NVCT Hedge Fund Activity: Q1 2024 in Review

40 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Nuvectis Pharma (NVCT) for Q1 2024, worth a combined $12.8M — down 0.03% from $12.8M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NVCT positions and 2 closed out — a net gain of 4 holders — while 15 added to existing stakes and 12 trimmed.

The largest buyer was Marshall Wace, adding an estimated $215K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $214K sold.

  • 40 institutional investors held Nuvectis Pharma (NVCT) as of Q1 2024, up from 36 in Q4 2023.
  • Funds reported $12.8M of Nuvectis Pharma stock for Q1 2024, down 0.03% quarter-over-quarter.
  • 6 funds opened new Nuvectis Pharma positions in Q1 2024 and 2 closed out, a net change of +4 holders.
  • The largest Nuvectis Pharma buyer in Q1 2024 was Marshall Wace, an estimated $215K added.
  • The largest Nuvectis Pharma seller in Q1 2024 was Susquehanna International Group, an estimated $214K sold.

Based on aggregated 13F filings for Q1 2024.